Nyxoah SA

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: BE0974358906

EUR

4.12

-0.04 (-0.96%)

Dec 04

BRU

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Ion Beam Applications SA

MDxHealth SA

Nyxoah SA

Sequana Medical NV

Biocartis Group NV

Why is Nyxoah SA ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate -186.94% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -27.33

Flat results in Dec 20

INTEREST(HY) At EUR 0.57 MM has Grown at 61.69%
PRE-TAX PROFIT(Q) At EUR -8.21 MM has Fallen at -125.82%
NET PROFIT(Q) At EUR -8.28 MM has Fallen at -124.51%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -46.29%, its profits have fallen by -79.3%

Below par performance in long term as well as near term

Along with generating -46.29% returns in the last 1 year, the stock has also underperformed Belgium BEL 20 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nyxoah SA for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Nyxoah SA

-46.29%

-0.72

69.45%

Belgium BEL 20

17.57%

1.10

15.92%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

41.75%

EBIT Growth (5y)

-186.94%

EBIT to Interest (avg)

-27.33

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.47

Sales to Capital Employed (avg)

1.08

Tax Ratio

4.97%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.99%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.37

EV to EBIT

-2.03

EV to EBITDA

-2.11

EV to Capital Employed

2.99

EV to Sales

30.66

PEG Ratio

Dividend Yield

ROCE (Latest)

-147.37%

ROE (Latest)

-106.46%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is not working for Nyxoah SA

Interest

At EUR 0.57 MM has Grown at 61.69%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)

Pre-Tax Profit

At EUR -8.21 MM has Fallen at -125.82%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (EUR MM)

Net Profit

At EUR -8.28 MM has Fallen at -124.51%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (EUR MM)